Aptevo Therapeutics Inc. Public Float
Aptevo Therapeutics Inc. (APVO) had Public Float of $9.80 million as of 2025-06-30, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-26
- 2025-06-30: Entity Public Float $9.80M.
- 2024-06-30: Entity Public Float $1.20M.
- 2023-06-30: Entity Public Float $11.00M.
- 2022-06-30: Entity Public Float $18.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $9.80M 10-K · filed 2026-03-26 |
| 2024-06-30 | $1.20M 10-K · filed 2025-02-14 |
| 2023-06-30 | $11.00M 10-K · filed 2024-03-05 |
| 2022-06-30 | $18.00M 10-K · filed 2023-03-30 |
| 2021-06-30 | $93.10M 10-K · filed 2022-03-24 |
| 2020-06-30 | $24.10M 10-K/A · filed 2021-04-28 |
| 2019-06-30 | $36.60M 10-K · filed 2020-03-25 |
| 2018-06-30 | $90.10M 10-K · filed 2019-03-18 |
| 2017-06-30 | $35.80M 10-K · filed 2018-03-13 |
| 2016-06-30 | $30.80M 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |